New indication will do little to raise hopes

Anonymous

Guest
Just a thought...I used to sell a fibrate that is now generic and our indication for any trigs over 250 really meant nothing to most MDs. Your Competition is used because of non-indicated benefits. Take that away and to only sell this product off of cardio benefits gets minimal RXs. Think your company living in clouds if they think your new indication will change your market place.
 






Just a thought...I used to sell a fibrate that is now generic and our indication for any trigs over 250 really meant nothing to most MDs. Your Competition is used because of non-indicated benefits. Take that away and to only sell this product off of cardio benefits gets minimal RXs. Think your company living in clouds if they think your new indication will change your market place.

Really??? You thought it was that important to post your thought at midnight on a Friday night? Obviously you just checked your brokage account and realized how much money you lost on this stock and thought you would vent here?? You do know what kind of site this is, don't you? Crazy people, don't gamble with money you cannot afford to lose!!
 






Just a thought...I used to sell a fibrate that is now generic and our indication for any trigs over 250 really meant nothing to most MDs. Your Competition is used because of non-indicated benefits. Take that away and to only sell this product off of cardio benefits gets minimal RXs. Think your company living in clouds if they think your new indication will change your market place.

Okay. I'll let the company know. We'll try to tamper enthusiasm because of your message board post. Thanks for helping us see our obvious path to failure. Where have you been all our lives? Do you do motivational speaking?... Or, life coaching?
 






There is a reason you "used" to sell anything. Moron. Go away go find a bridge! The market will grow by 10 times, I hate Obamacare but this preventative healthcare is the wave of the future . Insurance will be forced to pay for Vasepa.stock should be in the 50$ range!
 






the original poster is right. most rx for Vasepa are already off label. Anchor is by o means a multi billion dollar opportunity. if rick is telling you otherwise he is drinking Joe's koolaide. the FDA is having a formal review of Anchor because they are concerned and rightly so that Reduce-It isn't going to hit its endpoint.
if the best Lovaza did was under 1 billion and is now slowly sliding Amarin can not expect to ever exceed that. the product is expensive to make and much more expensive than GNC if you have a tier III copay. the quality factor isn't what it was when Lovaza was launched as Omacor. potency of non Rx omega 3s are not what they were years ago when you needed double the dose to equal Lovaza.
so when joe z goes back for a last ditch financing to be able to launch anchor, any hopes of a sale are gone. no major pharma wants us.
 










































Is there a head to head study I was not aware of ? Ahhhhhhh oh excuse me that was my fish belch!The lowering of HDL by 4% , why don't you explain the significance of that tome hmmmmmmmm? ( without belching!!!!!!) ha ha ha ha Did nt think so.
 






Is there a head to head study I was not aware of ? Ahhhhhhh oh excuse me that was my fish belch!The lowering of HDL by 4% , why don't you explain the significance of that tome hmmmmmmmm? ( without belching!!!!!!) ha ha ha ha Did nt think so.

A BILLION dollars in annual sales....burp! Can't touch this, rookie.
 






Yes after how many Yeats as the only omega 3 . Over 80% off label! The scam is over you will never see a billion again , generic around the corner. Mcdonalds is hiring! Ha ha ! You could be the fish filet specialist! Ha ha ha